Triple negative breast cancer (TNBC) represents a heterogenic subset of breast cancers which do not express the oestrogen (ER) and progesterone (PR) receptors and lack overexpression of the human epidermal growth factor receptor 2 (HER2)1,2. Here, ERBB2 is linked to breast carcinoma.